This morning, Credit Suisse lowered its EPS estimates on shares of Lam Research (NASDAQ:LRCX) through 2012 as capex spending is expected to slow across the industry. With the lower earnings estimates, Credit Suisse maintained its outperform rating, but set a new price target of $60 per share.
In morning trading, shares of LRCX were lower, falling 0.4% so far.
And UBS lowered its price target on shares of Marathon Oil (NYSE:MRO) to $40 as the company completed its spin-off of Marathon Petroleum (NYSE:MPC) this week. With the lower price target, UBS maintained its buy rating.
Shares of MRO were higher on Friday, gaining 1.4% today.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.